All multiple sclerosis articles
-
NewsEpstein-Barr Virus and brain cross-reactivity: possible mechanism for multiple sclerosis unveiled
The role that Epstein-Barr Virus (EBV) plays in the development of multiple sclerosis (MS) may be caused by a higher level of cross-reactivity, where the body’s immune system binds to the wrong target, than previously thought.
-
NewsMultiple sclerosis: Possible basis for vaccine researched
Researchers have shown that the risk of MS is particularly high in people with a combination of certain host factors and variants of the Epstein-Barr virus (EBV).
-
NewsHERV-W virus acting as neuropathogen successfully confirmed
Scientists have described a direct functional connection between the release of an endogenous retrovirus and the worsening of neurodegenerative processes in multiple sclerosis.
-
NewsEngineered probiotic developed to treat multiple sclerosis
Researchers are working on a new approach to target autoimmunity in the brain, leveraging designer bacteria to make treatment safer and more effective.
-
NewsBacteria with anti-inflammatory effects found in gut of sclerosis patients with no evidence of active disease
Multiple sclerosis patients do not have the same bacteria in their intestines as healthy people. There are also differences in the composition and function of the bacteria in the intestines of multiple sclerosis patients, depending on whether their illness is active, and whether they are in treatment, a new study shows.
-
NewsPoor gut health may drive multiple sclerosis — but better diet may ease it
Researchers have traced a previously observed link between microscopic organisms in the digestive tract — collectively known as the gut microbiome — and multiple sclerosis (MS).
-
NewsNew research unit awarded €6m to investigate gut-brain axis
The German Research Foundation (DFG) is funding a new clinical research unit that will investigate the interaction between the digestive and nervous systems with reference to inflammatory and degenerative diseases, the first collaborative research group in Germany to explore the “gut-brain axis”.
-
NewsExperimental monoclonal antibodies take the fight to Epstein-Barr virus
Researchers have discovered a panel of investigational monoclonal antibodies (mAbs) targeting different sites of the Epstein-Barr virus (EBV) blocked infection when tested in human cells in a laboratory setting.
